Gastric Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection for the Treatment of Refractory Gastroparesis: A Cost-Effectiveness Analysis.

Saved in:
Bibliographic Details
Title: Gastric Peroral Endoscopic Myotomy Versus Botulinum Toxin Injection for the Treatment of Refractory Gastroparesis: A Cost-Effectiveness Analysis.
Authors: Sonaiya S; Department of Internal Medicine, University of Nevada Las Vegas, Las Vegas, NV., Dahiya DS; Department of Gastroenterology, Hepatology and Motility, University of Kansas School of Medicine, Kansas City, KS., Tun KM; Department of Internal Medicine, Division of Gastroenterology and Hepatology, Creighton University School of Medicine, Omaha, NE., Mange P; Department of Internal Medicine, Jacobi Hospital/Albert Einstein College of Medicine, New York City, NY., Inamdar S; Department of Gastroenterology and Hepatology, University of Arkansas for Medical Sciences, Little Rock, AR., Chandan S; Advanced Endoscopy, Houston Methodist Gastroenterology Associates, Houston Methodist West Hospital, Houston, TX., Mohan BP; University of Central Florida School of Medicine.; Orlando Gastroenterology PA, Orlando, FL., Adler DG; Department of Gastroenterology and Hepatology, Advent Health Porter, Denver, CO.
Source: Journal of clinical gastroenterology [J Clin Gastroenterol] 2026 Jul 01; Vol. 60 (6), pp. 514-522. Date of Electronic Publication: 2026 Jul 01.
Publication Type: Journal Article; Comparative Study
Journal Info: Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 7910017 Publication Model: Electronic Cited Medium: Internet ISSN: 1539-2031 (Electronic) Linking ISSN: 01920790 NLM ISO Abbreviation: J Clin Gastroenterol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1539-2031
DOI:10.1097/MCG.0000000000002368